Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis
- PMID: 22825272
- DOI: 10.1097/AOG.0b013e31825935d4
Pregnancy outcome in anti-N-methyl-D-aspartate receptor encephalitis
Abstract
Background: Anti-N-methyl-D-aspartate (NMDA) receptor encephalitis is an autoimmune disorder resulting in neurologic and psychiatric symptoms. Treatment is challenging in pregnancy, because little data exist to guide management.
Case: A 24-year-old woman with a known diagnosis of anti-NMDA receptor encephalitis using intravenous immunoglobulin therapy became pregnant. Her pregnancy was uncomplicated with no relapses. She delivered at 35 4/7 weeks of gestation after having preterm premature rupture of membranes. She had a relapse of symptoms after delivery.
Conclusion: This patient with anti-NMDA receptor encephalitis had an uneventful pregnancy with overall good outcome; however, she experienced relapse soon after delivery. This disease may mimic other autoimmune diseases, with improvement during pregnancy and risk for relapse postpartum.
References
-
- Dalmau J, Gleichman AJ, Hughes EG, Rossi JE, Peng X, Lai M, et al.. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091–8.
-
- Rosenfeld MR, Dalmau J. Anti-NMDA-receptor encephalitis and other synaptic autoimmune disorders. Curr Treat Options Neurol 2011;13:324–32.
-
- Kumar MA, Jain A, Dechant VE, Saito T, Rafael T, Aizawi H, et al.. Anti-N-methyl-D-aspartate receptor encephalitis during pregnancy. Arch Neurol 2010;67:884–7.
-
- Ito Y, Abe T, Tomioka R, Komori T, Araki N. Anti-NMDA receptor encephalitis during pregnancy. Rinsho Shinkeigaku 2010;50:103–7.
-
- Dalmau J, Tuzun E, Wu HY, Masjuan J, Rossi JE, Voloschin A, et al.. Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25–36.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical